Macular degeneration: open trials in Austria

• NCT06847542

  A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD

  Trial Treatment · Phase 3 · Hoffmann-La Roche

  Medizinische Universitaet Innsbruck, Innsbruck · Johannes Kepler University Linz, Linz · NOE Landesgesundheitsagentur, Mistelbach

  Registry updated 2026-11-06

• NCT06541704

  A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  Trial Treatment · Phase 3 · Regeneron Pharmaceuticals

  Medical University of Graz, Graz · Hanusch Krankenhaus der Wiener Gebietskrankenkasse, Vienna · Medical University of Vienna, Vienna

  Registry updated 2026-11-05

• NCT07007065

  Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

  Trial Treatment · Phase 3 · AbbVie

  Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Johannes Kepler University Linz, Linz · NOE Landesgesundheitsagentur, Mistelbach · Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg

  Registry updated 2026-10-29

• NCT03683251

  Extension Study for the Port Delivery System With Ranibizumab (Portal)

  Trial Treatment · Phase 3 · Hoffmann-La Roche

  Medical University of Graz, Graz · Medical University of Vienna, Vienna

  Registry updated 2026-10-27

• 2025-524894-17-00

  A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003)

  Trial Treatment · Phase 2/3 · Eyebiotech Limited

  Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Medical University of Vienna, Vienna · Institut Fuer Forschung Und Innovation In Der Augenchirurgie, Vienna

  Registry updated 2026-09-10

• NCT06659445

  Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  Trial Treatment · Phase 2 · ONL Therapeutics

  Konvent Der Barmherzigen Brueder, Linz · Medical University of Vienna, Vienna · Institut Fuer Forschung Und Innovation In Der Augenchirurgie, Vienna

  Registry updated 2026-09-10

• NCT06990269

  Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

  Trial Treatment · Phase 2 · ADARx Pharmaceuticals, Inc.

  Graz · Innsbruck · Vienna

  Registry updated 2026-09-03

• NCT03011541

  Stem Cell Ophthalmology Treatment Study II

  Trial Treatment · MD Stem Cells

  MD Stem Cells Kobinia Med, Vienna

  Registry updated 2026-06-29

• 2025-523478-17-00

  Two initial aflibercept 8 mg loading doses in treatment-naive neovascular AMD

  Trial Treatment · Phase 4 · Medical University Of Graz

  Medical University of Graz, Graz

  Registry updated 2026-02-16

• NCT03921931

  Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study

  Trial Treatment · Medical University of Vienna

  Medical University of Vienna, Department of Clinical Pharmacology, Vienna

  Registry updated 2025-05-16

• NCT06351657

  Personalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression

  Research · Medical University of Vienna

  Medical University of Vienna, Vienna

  Registry updated 2025-05-15

• NCT06351670

  Personalised Monitoring of Early and Intermediate Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression

  Research · Medical University of Vienna

  Medical University of Vienna, Vienna

  Registry updated 2025-05-15

• NCT02669953

  Aflibercept in Recurrent or Persistent CNV

  Research · Medical University of Vienna

  Medical University of Vienna, Vienna

  Registry updated 2024-11-26

• NCT05093374

  Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting

  Trial Treatment · Phase 4 · Medical University of Vienna

  Department of Ophthalmology, Medical University of Vienna, Austria, Vienna

  Registry updated 2024-11-25

• NCT06682455

  Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - SUMMIT (Part 2)

  Research · University of Southampton

  Medical University of Vienna, Vienna

  Registry updated 2024-11-12

• NCT06074731

  Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography

  Research · Johannes Kepler University of Linz

  Department for Ophthalmology and Optometry, Kepler University Hospital GmbH, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria, Linz

  Registry updated 2023-10-10

All Macular degeneration trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error